NO20004664L - FremgangsmÕte for fremstilling av HIV proteaseinhibitorer - Google Patents

FremgangsmÕte for fremstilling av HIV proteaseinhibitorer

Info

Publication number
NO20004664L
NO20004664L NO20004664A NO20004664A NO20004664L NO 20004664 L NO20004664 L NO 20004664L NO 20004664 A NO20004664 A NO 20004664A NO 20004664 A NO20004664 A NO 20004664A NO 20004664 L NO20004664 L NO 20004664L
Authority
NO
Norway
Prior art keywords
preparation
protease inhibitors
hiv protease
hiv
inhibitors
Prior art date
Application number
NO20004664A
Other languages
English (en)
Other versions
NO317648B1 (no
NO20004664D0 (no
Inventor
Stephen Mcghie
Stephen Rout
Hardev Sinhgh
David D Deininger
Emile Al-Farhan
John Mark O'callaghan
Mark Stuart Robertson
Keith Rodgers
Roger Dennis Tung
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20004664L publication Critical patent/NO20004664L/no
Publication of NO20004664D0 publication Critical patent/NO20004664D0/no
Publication of NO317648B1 publication Critical patent/NO317648B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
NO20004664A 1998-03-20 2000-09-19 Fremgangsmate for fremstilling av HIV proteaseinhibitorer NO317648B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9805898.5A GB9805898D0 (en) 1998-03-20 1998-03-20 Process for the sythesis of hiv protease inhibitors
PCT/GB1999/000852 WO1999048885A1 (en) 1998-03-20 1999-03-18 Process for the synthesis of hiv protease inhibitors

Publications (3)

Publication Number Publication Date
NO20004664L true NO20004664L (no) 2000-09-19
NO20004664D0 NO20004664D0 (no) 2000-09-19
NO317648B1 NO317648B1 (no) 2004-11-29

Family

ID=10828884

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004664A NO317648B1 (no) 1998-03-20 2000-09-19 Fremgangsmate for fremstilling av HIV proteaseinhibitorer

Country Status (32)

Country Link
US (1) US6281367B1 (no)
EP (1) EP1066276B1 (no)
JP (1) JP3363439B2 (no)
KR (1) KR100555278B1 (no)
CN (1) CN1308319C (no)
AP (1) AP1226A (no)
AT (1) ATE242772T1 (no)
AU (1) AU751534B2 (no)
BR (1) BR9908970A (no)
CA (1) CA2324217C (no)
CZ (1) CZ299193B6 (no)
DE (1) DE69908761T2 (no)
DK (1) DK1066276T3 (no)
EA (1) EA003022B1 (no)
EE (1) EE04750B1 (no)
ES (1) ES2203090T3 (no)
GB (1) GB9805898D0 (no)
HK (1) HK1032047A1 (no)
HR (1) HRP20000609B1 (no)
HU (1) HUP0105439A3 (no)
ID (1) ID26587A (no)
IL (1) IL138127A (no)
IS (1) IS2273B (no)
NO (1) NO317648B1 (no)
NZ (1) NZ506563A (no)
PL (1) PL201810B1 (no)
PT (1) PT1066276E (no)
RS (1) RS49954B (no)
SK (1) SK283939B6 (no)
TR (1) TR200002698T2 (no)
WO (1) WO1999048885A1 (no)
ZA (1) ZA200004482B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843946A (en) 1992-08-25 1998-12-01 G.D. Searle & Co. α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
US6548706B2 (en) * 1999-12-23 2003-04-15 Aerojet Fine Chemicals Llc Preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl) -p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines
EP2314564A3 (en) * 1999-12-23 2012-04-04 Ampac Fine Chemicals LLC Improved preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines
HUE034389T2 (en) 2002-05-16 2018-02-28 Janssen Sciences Ireland Uc Pseudopolymorphic forms of an HIV protease inhibitor
US7772411B2 (en) 2003-12-23 2010-08-10 Tibotec Pharmaceuticals Ltd. Process for the preparation of (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate
AR073248A1 (es) 2008-09-01 2010-10-20 Tibotec Pharm Ltd Proceso para la preparacion de (1s, 2r)-3- ((4-aminofenil) sulfonil) ( isobutil) amino)-1- bencil-2- hidroxipropilcarbamato de (3r, 3as,6ar)- hexahidrofuro-(2,3-b) furan-3- ilo (darunavir) y compuestos intermediarios utiles en dicho proceso.
AP3551A (en) 2010-01-27 2016-01-18 Viiv Healthcare Co Antiviral therapy
WO2012032389A2 (en) 2010-09-10 2012-03-15 Lupin Limited Process for preparation of substantially pure fosamprenavir calcium and its intermediates
CN111233794A (zh) * 2020-03-27 2020-06-05 江巨东 一种安普那韦的精制方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1071930A (zh) * 1991-07-10 1993-05-12 伊莱利利公司 用作治疗艾滋病的人免疫缺陷病毒蛋白酶的抑制剂
US5843946A (en) * 1992-08-25 1998-12-01 G.D. Searle & Co. α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða

Also Published As

Publication number Publication date
EP1066276A1 (en) 2001-01-10
IS2273B (is) 2007-07-15
CA2324217A1 (en) 1999-09-30
ZA200004482B (en) 2001-11-28
CN1308319C (zh) 2007-04-04
CZ299193B6 (cs) 2008-05-14
EA003022B1 (ru) 2002-12-26
YU55900A (sh) 2003-02-28
HUP0105439A2 (en) 2002-06-29
IS5605A (is) 2000-08-29
CZ20003457A3 (cs) 2001-04-11
CN1293668A (zh) 2001-05-02
WO1999048885A1 (en) 1999-09-30
EP1066276B1 (en) 2003-06-11
GB9805898D0 (en) 1998-05-13
HRP20000609A2 (en) 2001-04-30
AP1226A (en) 2003-11-21
CA2324217C (en) 2008-02-19
AP2000001911A0 (en) 2000-09-30
KR100555278B1 (ko) 2006-03-03
RS49954B (sr) 2008-09-29
SK283939B6 (sk) 2004-05-04
US6281367B1 (en) 2001-08-28
KR20010042022A (ko) 2001-05-25
ATE242772T1 (de) 2003-06-15
TR200002698T2 (tr) 2000-12-21
HK1032047A1 (en) 2001-07-06
NO317648B1 (no) 2004-11-29
HUP0105439A3 (en) 2002-08-28
IL138127A0 (en) 2001-10-31
AU2947599A (en) 1999-10-18
EA200000859A1 (ru) 2001-04-23
ID26587A (id) 2001-01-18
DK1066276T3 (da) 2003-10-06
DE69908761T2 (de) 2004-02-19
AU751534B2 (en) 2002-08-22
JP3363439B2 (ja) 2003-01-08
EE04750B1 (et) 2006-12-15
PL201810B1 (pl) 2009-05-29
EE200000568A (et) 2002-02-15
JP2002507609A (ja) 2002-03-12
DE69908761D1 (de) 2003-07-17
NZ506563A (en) 2003-05-30
PT1066276E (pt) 2003-10-31
PL342602A1 (en) 2001-06-18
IL138127A (en) 2003-10-31
NO20004664D0 (no) 2000-09-19
HRP20000609B1 (en) 2006-05-31
ES2203090T3 (es) 2004-04-01
SK13732000A3 (sk) 2001-08-06
BR9908970A (pt) 2000-11-28

Similar Documents

Publication Publication Date Title
DK1085981T3 (da) Fremgangsmåde til emballering
NO990548L (no) Inhibitorer for cystein-protease
CY2007029I1 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
NO20003692D0 (no) Bisulfat-salt av HIV-protease-inhibitor
NO20004219D0 (no) Inhibitorer av fosfolipaseenzymer
NO20004220L (no) Inhibitorer av fosfolipaseenzymer
CY2013011I2 (el) Μεθοδος χορηγησης διφωσφονικων
NO20012980L (no) Proteaseinhibitorer
DK1114051T3 (da) Inhibitorer for p38
PT1086076E (pt) Inibidores de sulfonamida de aspartil protease
NO20016034L (no) Inhibitorer av aspartylprotease
ID26990A (id) Metode pembuatan dimetilnaftalena
NO20032822D0 (no) Fremgangsmåte for konsentrering av brukt syre
EE04154B1 (et) Omeprasooli valmistamise meetod
NO20004664L (no) FremgangsmÕte for fremstilling av HIV proteaseinhibitorer
DK0987356T3 (da) Fremgangsmåde til trækning
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
AU5089699A (en) Methods of making dihydropyrone hiv protease inhibitors
FI20000325A0 (fi) Menetelmä rakenteen rasituksen määrittämiseksi
NO20001985L (no) FremgangsmÕte for forming av strimmelformede folier
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod
EE9900109A (et) Vaheühendid HIV-proteaasi inhibiitorite valmistamiseks ja HIV-proteaasi inhibiitorite valmistamismeetodid
SE9803550D0 (sv) Method of application
SE9802223D0 (sv) Method of application
UA25626A (uk) Спосіб виготовлеhhя пива

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees